Mean HBV DNA levels of all (A) and virologic breakthrough (B) patients according to the time points of nucleot(s)ide analogues therapy.

HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analogues Therapy

Yeh Ming-Lun
Huang Chung-Feng
Huang Ching-I
Liu Shu-Fen
Yang Hua-Ling
Hsieh Ming-Yen
Huang Jee-Fu
Dai Chia-Yen
Chuang Wan-Long
Yu Ming-Lung

July 2014

Selection of drug-resistant strains may lead to failure of HBV antiviral therapy. There is little in...

Clinical and virological data from 6 vaccinated subjects demonstrated to be HBV DNA positive by both the nested PCR protocol and VERSANT HBV DNA 3.0 assay.

Hong Kim (101826)
Jeong-Ryeol Gong (803506)
Seoung-Ae Lee (101834)
Bum-Joon Kim (101858)

October 2015

aThe normal range of ALT (IU/L) is less than or equal to 41.bAnti-HB...

Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha

van der Eijk, A A
Niesters, H G M
Hansen, B E
Heijtink, R A
Janssen, H L A
Schalm, S W
de Man, R A

February 2006

To reduce unnecessary exposure to treatment, physicians must decide at an early stage whether contin...

HBV DNA quantification.

Alexandra Ducancelle (483489)
Pierre Abgueguen (483490)
Jacques Birguel (483491)
Wael Mansour (483492)
Adeline Pivert (483493)
Hélène Le Guillou-Guillemette (483494)
Jean-Jacques Sobnangou (483495)
Amélie Rameau (483496)
Jean-Marie Huraux (483497)
Françoise Lunel-Fabiani (483498)

November 2013

Serum HBV DNA levels were quantified in 72 consecutive samples with the Abbott Real Time HBV PCR ...

Individual HBV DNA level of the 3 patients with persist detectable DNA by RealTime, but undetectable by TaqMan assay and developed YMDD mutation.

Ming-Lun Yeh (349881)
Chung-Feng Huang (292606)
Ching-I Huang (391259)
Shu-Fen Liu (299474)
Hua-Ling Yang (593699)
Ming-Yen Hsieh (391260)
Jee-Fu Huang (292609)
Chia-Yen Dai (292610)
Wan-Long Chuang (292615)
Ming-Lung Yu (292600)

July 2014

Individual HBV DNA level of the 3 patients with persist detectable DNA by RealTime, but un...

The correlation of measurements and limits of agreement between RealTime and TaqMan assay in the 434 samples of HBV DNA level <3 log10 IU/mL.

Ming-Lun Yeh (349881)
Chung-Feng Huang (292606)
Ching-I Huang (391259)
Shu-Fen Liu (299474)
Hua-Ling Yang (593699)
Ming-Yen Hsieh (391260)
Jee-Fu Huang (292609)
Chia-Yen Dai (292610)
Wan-Long Chuang (292615)
Ming-Lung Yu (292600)

July 2014

The correlation of HBV DNA in the 434 samples between the two assays was not as good as all sampl...

The correlation of measurements and limits of agreement between RealTime and TaqMan assay in all 571 serum samples.

Ming-Lun Yeh (349881)
Chung-Feng Huang (292606)
Ching-I Huang (391259)
Shu-Fen Liu (299474)
Hua-Ling Yang (593699)
Ming-Yen Hsieh (391260)
Jee-Fu Huang (292609)
Chia-Yen Dai (292610)
Wan-Long Chuang (292615)
Ming-Lung Yu (292600)

July 2014

The correlation of HBV DNA observed between the RealTime and TaqMan assays was good (R<sup...

Univariate analyses of the factors correlated with HBV virological response and reactivation of HBV.

Xiaoyan Guo (228186)
Guilin Yang (583364)
Jin Yuan (120922)
Peng Ruan (583365)
Mingxia Zhang (191591)
Xincun Chen (583366)
Boping Zhou (122162)

October 2013

+ HBV DNA detectable by a real-time PCR ( ≥200 IU/mL).HBV DNA not detectable by a real-t...

HBV DNA ASSAYS: (METHODS AND PRACTICAL USE) AND VIRAL KINETICS

July 2015

Print this page The presence of HBV DNA in peripheral blood is a reliable marker of active HBV repli...

Abbott RealTime HBV assay is more sensitive in detection of low viral load and little impacted by drug resistant mutation in chronic hepatitis B patients under nucleot(s)ide analogues therapy.

Ming-Lun Yeh
Chung-Feng Huang
Ching-I Huang
Shu-Fen Liu
Hua-Ling Yang
Ming-Yen Hsieh
Jee-Fu Huang
Chia-Yen Dai
Wan-Long Chuang
Ming-Lung Yu

BACKGROUND: Selection of drug-resistant strains may lead to failure of HBV antiviral therapy. There ...

Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays

Pas, S D
Fries, E
De Man, R A
Osterhaus, A D
Niesters, H G

August 2000

A highly reproducible and sensitive real-time detection assay based on TaqMan technology was develop...

HBV-RNA Co-amplification May Influence HBV DNA Viral Load Determination.

Maasoumy, Benjamin
Geretti, Anna Maria
Frontzek, André
Austin, Harrison
Aretzweiler, Gudrun
Garcia-Álvarez, Monica
Leuchter, Susanne
Simon, Christian O
Marins, Ed G
Canchola, Jesse A
Cornberg, Markus
Delgado, Rafael
Wedemeyer, Heiner

May 2020

Despite effective hepatitis B virus (HBV)-DNA suppression, HBV RNA can circulate in patients receivi...

Comparison of two methods for quantification of hepatitis B viral DNA

高嘉宏
KAO, JIA-HORNG

September 2009

BACKGROUND: Quantitation of serum hepatitis B virus (HBV) DNA has proven useful in assisting with pa...

Prospective comparison of Abbott RealTime HBV DNA and Versant HBV DNA 3.0 assays for hepatitis B DNA quantitation: Impact on HBV genotype monitoring

Pol, Jonathan
Le Pendeven, Catherine
Beby-Defaux, Agnès
Rabut, Elodie
Jais, Jean,
Pilloux, Marilyse
Osada, Catherine
Zatla, Fadila
Assami, Hichem
Didier Grange, Jean
Kremsdorf, Dina
Nicolas, Jean,
Soussan, Patrick

January 2008

International audienceThe quantitation of human hepatitis B virus (HBV) in the serum of infected pat...

Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy

Bowden, S
Lee, NP
Hui, CK
Zhang, HY
Wong, A
Lewin, S
Rousseau, F
MommejaMarin, H
Locarnini, S
Leung, N
Naoumov, NV
Luk, JM
Lau, GKK

January 2006

The performance characteristics of the RealART and Molecular Beacons assays were compared with those...

HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analogues Therapy

Yeh Ming-Lun
Huang Chung-Feng
Huang Ching-I
Liu Shu-Fen
Yang Hua-Ling
Hsieh Ming-Yen
Huang Jee-Fu
Dai Chia-Yen
Chuang Wan-Long
Yu Ming-Lung

July 2014

Selection of drug-resistant strains may lead to failure of HBV antiviral therapy. There is little in...

Clinical and virological data from 6 vaccinated subjects demonstrated to be HBV DNA positive by both the nested PCR protocol and VERSANT HBV DNA 3.0 assay.

Hong Kim (101826)
Jeong-Ryeol Gong (803506)
Seoung-Ae Lee (101834)
Bum-Joon Kim (101858)

October 2015

aThe normal range of ALT (IU/L) is less than or equal to 41.bAnti-HB...

Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha

van der Eijk, A A
Niesters, H G M
Hansen, B E
Heijtink, R A
Janssen, H L A
Schalm, S W
de Man, R A

February 2006

To reduce unnecessary exposure to treatment, physicians must decide at an early stage whether contin...

HBV DNA quantification.

Alexandra Ducancelle (483489)
Pierre Abgueguen (483490)
Jacques Birguel (483491)
Wael Mansour (483492)
Adeline Pivert (483493)
Hélène Le Guillou-Guillemette (483494)
Jean-Jacques Sobnangou (483495)
Amélie Rameau (483496)
Jean-Marie Huraux (483497)
Françoise Lunel-Fabiani (483498)

November 2013

Serum HBV DNA levels were quantified in 72 consecutive samples with the Abbott Real Time HBV PCR ...

Individual HBV DNA level of the 3 patients with persist detectable DNA by RealTime, but undetectable by TaqMan assay and developed YMDD mutation.

Ming-Lun Yeh (349881)
Chung-Feng Huang (292606)
Ching-I Huang (391259)
Shu-Fen Liu (299474)
Hua-Ling Yang (593699)
Ming-Yen Hsieh (391260)
Jee-Fu Huang (292609)
Chia-Yen Dai (292610)
Wan-Long Chuang (292615)
Ming-Lung Yu (292600)

July 2014

Individual HBV DNA level of the 3 patients with persist detectable DNA by RealTime, but un...

The correlation of measurements and limits of agreement between RealTime and TaqMan assay in the 434 samples of HBV DNA level <3 log10 IU/mL.

Ming-Lun Yeh (349881)
Chung-Feng Huang (292606)
Ching-I Huang (391259)
Shu-Fen Liu (299474)
Hua-Ling Yang (593699)
Ming-Yen Hsieh (391260)
Jee-Fu Huang (292609)
Chia-Yen Dai (292610)
Wan-Long Chuang (292615)
Ming-Lung Yu (292600)

July 2014

The correlation of HBV DNA in the 434 samples between the two assays was not as good as all sampl...

The correlation of measurements and limits of agreement between RealTime and TaqMan assay in all 571 serum samples.

Ming-Lun Yeh (349881)
Chung-Feng Huang (292606)
Ching-I Huang (391259)
Shu-Fen Liu (299474)
Hua-Ling Yang (593699)
Ming-Yen Hsieh (391260)
Jee-Fu Huang (292609)
Chia-Yen Dai (292610)
Wan-Long Chuang (292615)
Ming-Lung Yu (292600)

July 2014

The correlation of HBV DNA observed between the RealTime and TaqMan assays was good (R<sup...

Univariate analyses of the factors correlated with HBV virological response and reactivation of HBV.

Xiaoyan Guo (228186)
Guilin Yang (583364)
Jin Yuan (120922)
Peng Ruan (583365)
Mingxia Zhang (191591)
Xincun Chen (583366)
Boping Zhou (122162)

October 2013

+ HBV DNA detectable by a real-time PCR ( ≥200 IU/mL).HBV DNA not detectable by a real-t...

HBV DNA ASSAYS: (METHODS AND PRACTICAL USE) AND VIRAL KINETICS

July 2015

Print this page The presence of HBV DNA in peripheral blood is a reliable marker of active HBV repli...

Abbott RealTime HBV assay is more sensitive in detection of low viral load and little impacted by drug resistant mutation in chronic hepatitis B patients under nucleot(s)ide analogues therapy.

Ming-Lun Yeh
Chung-Feng Huang
Ching-I Huang
Shu-Fen Liu
Hua-Ling Yang
Ming-Yen Hsieh
Jee-Fu Huang
Chia-Yen Dai
Wan-Long Chuang
Ming-Lung Yu

BACKGROUND: Selection of drug-resistant strains may lead to failure of HBV antiviral therapy. There ...

Development of a quantitative real-time detection assay for hepatitis B virus DNA and comparison with two commercial assays

Pas, S D
Fries, E
De Man, R A
Osterhaus, A D
Niesters, H G

August 2000

A highly reproducible and sensitive real-time detection assay based on TaqMan technology was develop...

HBV-RNA Co-amplification May Influence HBV DNA Viral Load Determination.

Maasoumy, Benjamin
Geretti, Anna Maria
Frontzek, André
Austin, Harrison
Aretzweiler, Gudrun
Garcia-Álvarez, Monica
Leuchter, Susanne
Simon, Christian O
Marins, Ed G
Canchola, Jesse A
Cornberg, Markus
Delgado, Rafael
Wedemeyer, Heiner

May 2020

Despite effective hepatitis B virus (HBV)-DNA suppression, HBV RNA can circulate in patients receivi...

Comparison of two methods for quantification of hepatitis B viral DNA

高嘉宏
KAO, JIA-HORNG

September 2009

BACKGROUND: Quantitation of serum hepatitis B virus (HBV) DNA has proven useful in assisting with pa...

Prospective comparison of Abbott RealTime HBV DNA and Versant HBV DNA 3.0 assays for hepatitis B DNA quantitation: Impact on HBV genotype monitoring

Pol, Jonathan
Le Pendeven, Catherine
Beby-Defaux, Agnès
Rabut, Elodie
Jais, Jean,
Pilloux, Marilyse
Osada, Catherine
Zatla, Fadila
Assami, Hichem
Didier Grange, Jean
Kremsdorf, Dina
Nicolas, Jean,
Soussan, Patrick

January 2008

International audienceThe quantitation of human hepatitis B virus (HBV) in the serum of infected pat...

Comparison of real-time PCR assays for monitoring serum hepatitis B virus DNA levels during antiviral therapy

Bowden, S
Lee, NP
Hui, CK
Zhang, HY
Wong, A
Lewin, S
Rousseau, F
MommejaMarin, H
Locarnini, S
Leung, N
Naoumov, NV
Luk, JM
Lau, GKK

January 2006

The performance characteristics of the RealART and Molecular Beacons assays were compared with those...

HBV Assay Is More Sensitive in Detection of Low Viral Load and Little Impacted by Drug Resistant Mutation in Chronic Hepatitis B Patients under Nucleot(s)ide Analogues Therapy

Yeh Ming-Lun
Huang Chung-Feng
Huang Ching-I
Liu Shu-Fen
Yang Hua-Ling
Hsieh Ming-Yen
Huang Jee-Fu
Dai Chia-Yen
Chuang Wan-Long
Yu Ming-Lung

July 2014

Selection of drug-resistant strains may lead to failure of HBV antiviral therapy. There is little in...

Clinical and virological data from 6 vaccinated subjects demonstrated to be HBV DNA positive by both the nested PCR protocol and VERSANT HBV DNA 3.0 assay.

Hong Kim (101826)
Jeong-Ryeol Gong (803506)
Seoung-Ae Lee (101834)
Bum-Joon Kim (101858)

October 2015

aThe normal range of ALT (IU/L) is less than or equal to 41.bAnti-HB...

Quantitative HBV DNA levels as an early predictor of nonresponse in chronic HBe-antigen positive hepatitis B patients treated with interferon-alpha

van der Eijk, A A
Niesters, H G M
Hansen, B E
Heijtink, R A
Janssen, H L A
Schalm, S W
de Man, R A

February 2006

To reduce unnecessary exposure to treatment, physicians must decide at an early stage whether contin...

Mean HBV DNA levels of all (A) and virologic breakthrough (B) patients according to the time points of nucleot(s)ide analogues therapy.

Abstract

Extracted data

Mean HBV DNA levels of all (A) and virologic breakthrough (B) patients according to the time points of nucleot(s)ide analogues therapy.

Abstract

Extracted data

Related items

Related items